- Report
- July 2022
- 122 Pages
United Kingdom
From €3293EUR$3,450USD£2,759GBP
- Report
- July 2023
- 113 Pages
Global
From €3500EUR$3,929USD£3,035GBP
The Zika Vaccine market is a subset of the larger Vaccines market. It is focused on the development of vaccines to protect against the Zika virus, a mosquito-borne virus that can cause severe birth defects in newborns. Vaccines are typically developed through a combination of public and private sector research and development, and the Zika Vaccine market is no exception. Vaccines are typically tested in clinical trials to ensure safety and efficacy before being approved for use.
The Zika Vaccine market is highly competitive, with a number of companies vying for a share of the market. Companies in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Johnson & Johnson, and Takeda Pharmaceuticals. These companies are actively researching and developing vaccines to protect against the Zika virus, with some already in clinical trials. Show Less Read more